Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma
| dc.contributor.author | Yavuz, S. | |
| dc.contributor.author | Yildirim, M. | |
| dc.contributor.author | Yazici, G. | |
| dc.contributor.author | Kaya, V. | |
| dc.contributor.author | Paydas, S. | |
| dc.date.accessioned | 2025-10-16T15:26:54Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, SEP 08-12, 2017 | |
| dc.identifier.other | WOS:000411324000320 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/8454 | |
| dc.publisher | OXFORD UNIV PRESS | |
| dc.source | ANNALS OF ONCOLOGY | |
| dc.title | Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma | |
| dc.type | Meeting Abstract |
